| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 142, 1794-1803, Copyright © 1993 by American Society for Investigative Pathology
REGULAR ARTICLES |
S Ibrahim, DV Dawson, P Van Trigt and F Sanfilippo
Department of Pathology, Duke University, Durham, North Carolina.
Subsets of T cells express different isoforms of the leukocyte common antigen CD45; those expressing the glycoprotein 220 isoform (CD45RA) have been characterized as naive in their response to antigens, and those expressing the glycoprotein 180 isoform (CD45RO) as memory T cells. The association between the rejection status of human cardiac allograft recipients and the relative infiltration of the CD45 subsets of both CD8+ and CD4+ T cells was examined using two-color immunohistological labeling techniques on 33 heart transplant biopsies, categorized by routine histological and clinical criteria as mild (requiring no treatment) or moderate (requiring antirejection therapy) rejection. Double-labeling was performed using pairs of monoclonal antibodies to define the following populations: CD4+ CD45RA+, CD4+ CD45RO+, CD8+ CD45RA+, and CD8+-CD45RO+. The number of cells per high- power field (HPF) for each of these cell subsets was counted in every biopsy. In cases with mild rejection, infiltration was predominant for CD4+ CD45RA+ cells (median = 5.0 cells/HPF) relative to CD4+ CD45RO+ (3.12 cells/HPF), CD8+ CD45RA+ (2.14 cells/HPF), and especially CD8+ CD45RO+ (1.22 cells/HPF) populations. In cases with moderate rejection, all four subpopulations increased but were essentially equivalent in intensity, such that in comparison to cases with mild rejection, the smallest increase was seen for CD4+ CD45RA+ cells (6.67 cells/HPF, P < 0.09) and the greatest for CD8+ CD45RO+ cells (7.00 cells/HPF, P < 0.002). A majority of CD8 cells expressed CD45RA in 14 of 16 (88%) cases of mild rejection compared to only 2 of 17 cases of moderate rejection. Moreover, the ratio of CD45RO+ to CD45RA+ cells in each biopsy was higher in moderate versus mild rejection for both CD4 (median ratios = 1.13 versus 0.68, respectively; P < 0.008) and CD8 (1.43 versus 0.58, respectively; P < 0.005) subsets. A majority of T cells expressed CD45RO in cases of moderate rejection (11 of 14 or 79%), compared to only 1 of 13 (8%) cases of mild rejection. These findings indicate that during generally self-limited mild acute cardiac allograft rejection there is a predominance of naive CD45RA+ T cells, especially of the CD4 phenotype, whereas during moderate rejection there is a significant shift toward activated CD45RO+ T cells, especially in the CD8 population.
This article has been cited by other articles:
![]() |
A. E. Anderson, B. L. Sayers, M. A. Haniffa, D. J. Swan, J. Diboll, X.-N. Wang, J. D. Isaacs, and C. M. U. Hilkens Differential regulation of naive and memory CD4+ T cells by alternatively activated dendritic cells J. Leukoc. Biol., July 1, 2008; 84(1): 124 - 133. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Takehisa, S. Sakiyama, T. Uyama, M. Sumitomo, M. Tamaki, H. Hino, M. Takehisa, M. Liu, K. Kondo, and Y. Monden Progressive increase of CD4+/CD45RC- lymphocytes after allograft rat lung transplantation: A marker of acute rejection J. Thorac. Cardiovasc. Surg., October 1, 2002; 124(4): 675 - 683. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Chen, C. Thoburn, and A. D. Hess Characterization of the Pathogenic Autoreactive T Cells in Cyclosporine-Induced Syngeneic Graft-Versus-Host Disease J. Immunol., December 15, 1998; 161(12): 7040 - 7046. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. Dollinger, S. E. M. howie, J. N. Plevris, A. M. Graham, P. C. Hayes, and D. J. Harrison Intrahepatic proliferation of `naive' and `memory' T cells during liver allograft rejection: primary immune response within the allograft FASEB J, August 1, 1998; 12(11): 939 - 947. [Abstract] [Full Text] |
||||
![]() |
C. Holzinger, A. Schollhammer, M. Imhof, C. Reinwald, G. Kramer, A. Zuckermann, E. Wolner, and G. Steiner Phenotypic Patterns of Mononuclear Cells in Dilated Cardiomyopathy Circulation, November 15, 1995; 92(10): 2876 - 2885. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |